GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Other Current Liabilities

Argenica Therapeutics (ASX:AGN) Other Current Liabilities : A$0.83 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Other Current Liabilities?

Argenica Therapeutics's other current liabilities for the quarter that ended in Dec. 2023 was A$0.83 Mil.

Argenica Therapeutics's quarterly other current liabilities increased from Dec. 2022 (A$0.03 Mil) to Jun. 2023 (A$0.03 Mil) and increased from Jun. 2023 (A$0.03 Mil) to Dec. 2023 (A$0.83 Mil).

Argenica Therapeutics's annual other current liabilities increased from Jun. 2021 (A$0.01 Mil) to Jun. 2022 (A$0.03 Mil) and increased from Jun. 2022 (A$0.03 Mil) to Jun. 2023 (A$0.03 Mil).


Argenica Therapeutics Other Current Liabilities Historical Data

The historical data trend for Argenica Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Other Current Liabilities Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23
Other Current Liabilities
- - -

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial - - - - -

Argenica Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Argenica Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Argenica Therapeutics (ASX:AGN) Business Description

Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines